Abstract
This article covers chemotherapy of malignant astrocytomas, ependymoma, and medulloblastoma. The future direction of anticancer drugs is discussed.
Publication types
-
Comparative Study
-
Research Support, U.S. Gov't, P.H.S.
-
Review
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Astrocytoma / drug therapy*
-
Astrocytoma / pathology
-
Brain Neoplasms / drug therapy*
-
Brain Neoplasms / pathology
-
Brain Stem
-
Child
-
Eflornithine
-
Ependymoma / drug therapy*
-
Ependymoma / pathology
-
Fluorouracil / administration & dosage
-
Glioblastoma / drug therapy
-
Glioblastoma / pathology
-
Humans
-
Hydroxyurea / administration & dosage
-
Lomustine / administration & dosage
-
Medulloblastoma / drug therapy*
-
Medulloblastoma / pathology
-
Methotrexate / administration & dosage
-
Mitoguazone / administration & dosage
-
Mitolactol / administration & dosage
-
Neoplasm Recurrence, Local
-
Ornithine / administration & dosage
-
Ornithine / analogs & derivatives
-
Prednisone / administration & dosage
-
Risk
-
Thioguanine / administration & dosage
-
Vincristine / administration & dosage
Substances
-
Vincristine
-
Lomustine
-
Ornithine
-
Thioguanine
-
Mitolactol
-
Mitoguazone
-
Fluorouracil
-
Prednisone
-
Hydroxyurea
-
Methotrexate
-
Eflornithine